Authors
Latest:
More Medications Means Changes to HIV Treatment GuidelinesThe HIV treatment update includes more considerations for coinfected patients and pregnant women than the previously published 2011 guidelines.
Latest:
Cost-Effectiveness of Fingolimod in Treating Patients With Relapsing-Remitting Multiple SclerosisFingolimod, a first-line, once-daily oral disease-modifying therapy for relapsing-remitting multiple sclerosis, has the lowest cost per relapse avoided compared with other first-line agents.
Latest:
Complementary Therapies and Patients With Cancer: Pearls for Avoiding Adverse EventsComplementary therapies, such as supplements or aromatherapy, have the potential to benefit patients with cancer, but can also trigger adverse events when they interact with oncology medications.
Latest:
Most Favored Nation Pricing Is More Political WhitewashHealth systems get just 36 days to make major administrative, information system, and operational changes amid the pandemic’s peak.
Latest:
Withdrawal of Inhaled Corticosteroids in Patients with Stable Chronic Obstructive Pulmonary DiseaseCOPD is the fourth leading cause of death in the United States, contributing to more than 120,000 deaths each year.
Latest:
WIDE-RANGING OPPORTUNITIES AT CARDINAL HEALTHMs. Rosendahl is a freelance writer based in Fort Lee, NJ.
Latest:
Hyperkalemia: Caught in a Bind?Hyperkalemia, used to describe an elevated level of potassium in the blood, occurs when there is a disturbance in the balance between intake and elimination or a shift of potassium between the intracellular and extracellular spaces.
Latest:
The Flu Vaccine Does Not Cause the FluMost pharmacists have probably heard numerous versions of these statements, always said emphatically and with conviction, and with a supporting story to boot.
Latest:
Redesigning Heart Failure Management to Optimize Patient and System OutcomesThis article reviews current drug therapies for heart failure and therapy integration into a patient care framework improving patient adherence, quality of life, and decreased risk of readmission to acute care facilities.
Latest:
Geriatric Cancers Present Many Therapeutic ChallengesPharmacists should develop treatment plans with an active interdisciplinary team and patient involvement.
Latest:
Hemophilia and Managed Care: Partnering to Achieve Cost-Effective CareExploring how health plans and hemophilia treatment centers can better work together to deliver high-quality care and manage costs associated with hemophilia.
Latest:
Management of VTE: 10 New RecommendationsDr. Tafreshi is professor and director of cardiology pharmacy practice residency at Midwestern University College of Pharmacy-Glendale (MWU-CPG), Glendale, Ariz. At the time of submission of this article, Dr. Patterson was a senior pharmacy student at MWU-CPG.
Latest:
Specialty Pharmacy in the European UnionRecent economic developments in Europe have impacted the state of specialty pharmacy. Here is an overview of the fluid situation and a comparison with the United States specialty market.
Latest:
The Democratization of Adverse Drug Event Reporting: The Movement Toward the Patient Experience and Individual Wellness GoalsTo help patients live the best possible life with their condition, we ultimately need to look beyond clinical trial data toward new and emerging sources of information that highlight the real world, longitudinal experience of a broader and more diverse patient population.
Latest:
Influenza Vaccine Considerations in the 65+ PopulationInfluenza vaccination decreases mortality and intensive care unit admissions and length of stay among patients who are 65 years and older.
Latest:
Clinical Practice Guidelines: Implications for the PharmacistKnowledge of clinical practice guidelines can protect pharmacists and patients.
Latest:
Offer Patients Counseling on ADFsPharmacists can extend education to prescribers and provide important guidance on abuse-deterrent opioid formulations.
Latest:
Let's Talk: Medication AdherenceIn an evolving and technology-driven world, mobile text messaging is a feasible electronic option to improve adherence, as more people from all socioeconomic classes and age groups are using this technology
Latest:
Five Technology Trends: Changing Pharmacy Practice Today and TomorrowHIT creates value for pharmacies and opportunities for pharmacists to use their professional skills in innovative ways in today's evolving value-based care systems.
Latest:
How P&T Committees Can Be Effective Change Agents: Part 2Understanding the factors necessary for successful change management will make this work more satisfying and rewarding for P&T committees.
Latest:
Biologic Management for IBDWith increased specialty medication prescribing, associated costs, and the interest of health systems to establish specialty pharmacies for improved patient care, it is vital to define the pharmacist's role within the patient's health care team.
Latest:
New Discoveries, New Challenges: Cystic Fibrosis and Inpatient CareA discussion of current and emerging pharmacotherapy options for cystic fibrosis patients.
Latest:
A Rotation Abroad: Rural Pharmacy Practice in Southern EcuadorWhat sets my time in Ecuador apart from any other rotation that I’ve done or will do is that every element of growth, and every challenge is presented simultaneously.
Latest:
First Biosimilar Filgrastim Launched TodayThe first biosimilar to receive FDA approval is now available the United States.
Latest:
Improving Transitions of Care for Patients With Acute Coronary Syndromes: A Focus on the Role of the Health System and Community Pharmacists on AdherenceThe intended audience for this activity consists of medical directors, pharmacy directors, pharmacy benefit managers, and other managed care professionals who are involved with the treatment of patients with acute coronary syndrome.
Latest:
National Diabetes Prevention Program Is Now Available in SpanishThe National DPP is an evidence-based lifestyle change program designed to delay or prevent the onset of type 2 diabetes among adults with prediabetes.
Latest:
CAR T-Cell Therapy: Genetically Programming the Immune System to Attack Malignant CellsCurrent FDA-approved CAR-T cell therapies express CARs recognizing CD19, which is expressed on the surface of almost all B cells, making these therapies specific for B-cell malignancies.
